6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neural Markers of Addiction Recovery
Advances in neuroscience have identified neural markers that play a pivotal role in addiction recovery. Brain imaging studies reveal changes in the prefrontal cortex, reward circuits, and stress-response systems during and after substance use. Neuroplasticity—the brain's ability to reorganize itself—facilitates recovery when supported by abstinence and behavioral therapies. Functional MRI (fMRI) and EEG studies have identified improved connectivity in regions associated with decision-making and impulse control during sustained recovery. Biomarkers like dopamine receptor availability and cortisol levels offer insights into the recovery process. Understanding these neural markers aids in developing targeted treatments, such as cognitive enhancers or neuromodulation, to promote long-term sobriety.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States